Dr Robert Stephen > CMS > London, England > Lawyer Profile
CMS Offices

CANNON PLACE
78 CANNON STREET
LONDON
EC4N 6AF
England
- Firm Profile
- Go to...
Dr Robert Stephen
Position
Partner
Patent Attorney, Co-Chair Life Sciences & Healthcare Sector
Career
Robert is a UK Chartered Patent Attorney and European Patent Attorney with over 20 years’ experience, and is qualified to act before the European Patent Office and the Unified Patent Court. He focusses on the biotechnology, pharmaceuticals and digital health spaces, and is ranked in band 1 in the Chambers legal directory in the UK. Robert is well known for his opposition and appeal practice at the EPO, and also as the co-founder of the SPC Blog, which leads the debate on issues relating to patent term extension in Europe. Robert has a first class degree in biochemistry and a D.Phil. in molecular genetics from Oxford University.
The patent attorney team, which Robert leads, has a focus on helping clients develop and exploit their IP to maximise commercial value. The team provides a complete range of services, including patent drafting and prosecution, licensing, strategic counselling, pan-European litigation and EPO opposition and appeal work. The team also advises on patent term extensions/SPCs, orphan exclusivity and data exclusivity.
Robert has experience in drafting, filing and prosecuting patent applications before the UK and EPO, patent licensing, global patent strategy, patent term extensions and portfolio management. He has been involved in over 50 EPO oppositions and appeals. Robert has a particular interest and expertise in inventions made in the fields of medical devices, pharmaceuticals, biochemistry, biotechnology, cell biology, genetics and immunology, including protein- and peptide-based medicines, vaccines, antibodies, nucleic acid-based medicines, diagnostic methods and diagnostic apparatus.
Education
- 1996 – D. Phil , Institute of Molecular Medicine, Oxford University, Oxford
- 1992 – Biochemistry, Oxford University, Oxford
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
CMS is praised for its ‘international capabilities and ‘broad range of expertise’ which encompasses commercial, regulatory, patent litigation and corporate work. Patent expert Robert Stephen leads the practice alongside Sarah Hanson and investment and development transactions specialist Candice Blackwood. Hanson excels in commercial, IP and outsourcing transactions. Shuna Mason is frequently sought out by medical device manufacturers for assistance with product liability mandates, while Brian Sher is a key contact for competition matters in the healthcare space. Glasgow-based Carina Healy ‘s commercial and IP expertise has made her a key contact for academic and research institutions on their research, licensing and commercial needs, and Healy’s Glasgow colleague David Dennis excels in clinical trial and collaboration agreements. Fionnuala Rice further augments the group’s patent litigation strength.
London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
(Leading partners)With European, UK, French, and Polish patent attorneys situated across the firm, the patent practice at CMS is well positioned to provide clients with a full-service offering, advising on both domestic and cross-border mandates, with the assistance of the firm’s wider litigation, regulatory, corporate, and commercial practices. With particular expertise in portfolio management for clients innovating in the biotechnology, pharmaceuticals, and medical devices spaces, Robert Stephen sits at the helm of the group, which frequently represents clients in EPO opposition cases. It is also well known in the technology and engineering sectors, acting for technology giants, as well as SMEs and start-ups. Freedom to operate and due diligence support for companies in the life science and pharmaceutical industries is another active area for the practice. Helen Wallis predominantly focuses on patent drafting and prosecution work in the technology sector, Jane Evenson is noted for her EPO opposition work, and Rachel Free is an expert in quantum computing. Another notable member of the team is Jane Hollywood, who is a biotechnology patent specialist.
Lawyer Rankings
- Leading partners London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
- PATMA: Patent attorneys London > TMT (technology, media and telecoms)
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Real estate > Commercial property: corporate occupiers
- Real estate > Commercial property: development
- Real estate > Commercial property: investment
- Real estate > Construction: contentious
- Real estate > Environment
- Corporate and commercial > Equity capital markets – small-mid cap
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- Crime, fraud and licensing > Fraud: civil
- Crime, fraud and licensing > Gaming and betting
- Insurance > Product liability: defendant
- Industry focus > Hospitality and leisure
- Projects, energy and natural resources > Infrastructure: Project finance and development
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- TMT (technology, media and telecoms) > IT and telecoms
- Insurance > Product liability: defendant
- TMT (technology, media and telecoms) > Media: Digital content & social
- TMT (technology, media and telecoms) > PATMA: Patent attorneys
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Real estate > Planning
- Projects, energy and natural resources > Power (including electricity and nuclear)
- Real estate > Property litigation
- Investment fund formation and management > Real estate funds
- Projects, energy and natural resources > Renewables
- Industry focus > Retail and consumer
- Investment fund formation and management > Retail funds
- Industry focus > TMT
Firm Rankings
- Corporate and commercial > Commercial contracts
- Real estate > Construction: non-contentious
- Risk advisory > Data protection, privacy and cybersecurity
- Employment > Employers
- Corporate and commercial > Financial services: contentious
- TMT (technology, media and telecoms) > Fintech: regulatory
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Insurance > Insurance and reinsurance litigation
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Industry focus > Life sciences and healthcare
- TMT (technology, media and telecoms) > Media: Advertising & marketing
- TMT (technology, media and telecoms) > Media: Film & TV
- TMT (technology, media and telecoms) > Media: Media finance
- Projects, energy and natural resources > Oil and gas
- TMT (technology, media and telecoms) > PATMA: Trade mark attorneys
- Dispute resolution > Professional discipline
- Insurance > Professional negligence
- Real estate > Property finance
- Transport > Rail
- TMT (technology, media and telecoms) > Sport
- Corporate and commercial > VAT and indirect tax
- Corporate and commercial > Venture capital
- Finance > Bank lending: investment grade debt and syndicated loans
- Dispute resolution > Banking litigation: investment and retail
- Insurance > Clinical negligence: defendant
- Dispute resolution > Commercial litigation: premium
- Corporate and commercial > Corporate tax
- Finance > Derivatives and structured products
- Employment > Employee share schemes
- Corporate and commercial > Financial services: non-contentious/regulatory
- Employment > Health and safety
- Dispute resolution > International arbitration
- Investment fund formation and management > Listed funds
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- TMT (technology, media and telecoms) > Media: Music
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- TMT (technology, media and telecoms) > Reputation management
- Public sector > Administrative and public law
- Transport > Aviation
- Dispute resolution > Competition litigation
- Finance > Corporate restructuring & insolvency
- Finance > Debt capital markets
- Corporate and commercial > Equity capital markets: mid-large cap
- Corporate and commercial > EU and competition
- Dispute resolution > Public international law
- Dispute resolution > Tax litigation and investigations
- Finance > Acquisition finance
- Finance > Transport finance and leasing
- Investment fund formation and management > Private funds